[Federal Register Volume 88, Number 61 (Thursday, March 30, 2023)]
[Rules and Regulations]
[Page 18987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06701]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
17 CFR Part 240
General Rules and Regulations, Securities Exchange Act of 1934
CFR Correction
This rule is being published by the Office of the Federal Register
to correct an editorial or technical error that appeared in the most
recent annual revision of the Code of Federal Regulations.
0
In Title 17 of the Code of Federal Regulations, Part 240, revised as of
April 1, 2022, in section 240.13e-100, reinstate the paragraphs at the
end of the section following ``Item 16. Exhibits'' to read as follows:
Sec. 240.13e-100 Schedule 13E-3, Transaction statement under section
13(e) of the Securities Exchange Act of 1934 and Rule 13e-3 (Sec.
240.13e-3) thereunder.
* * * * *
Signature. After due inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
-----------------------------------------------------------------------
(Signature)
-----------------------------------------------------------------------
(Name and title)
-----------------------------------------------------------------------
(Date)
Instruction to Signature: The statement must be signed by the
filing person or that person's authorized representative. If the
statement is signed on behalf of a person by an authorized
representative (other than an executive officer of a corporation or
general partner of a partnership), evidence of the representative's
authority to sign on behalf of the person must be filed with the
statement. The name and any title of each person who signs the
statement must be typed or printed beneath the signature. See Sec.
240.12b-11 with respect to signature requirements.
[FR Doc. 2023-06701 Filed 3-29-23; 8:45 am]
BILLING CODE 0099-10-P